Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01524926
Brief Title: CREATE: Cross-tumoral Phase 2 With Crizotinib (CREATE)

First Submitted : January 24, 2012
First Submitted that Met QC Criteria : January 31, 2012
First Posted : February 2, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 7, 2019
Last Update Posted : August 8, 2019